Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT00044044

Public ClinicalTrials.gov record NCT00044044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 3:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Week, Double-Blind, Randomized, Fixed-Dose, Parallel-Group Study of the Efficacy and Safety of Three Dose Levels of SM-13496 Compared to Placebo and Haloperidol in Patients With Schizophrenia Who Are Experiencing an Acute Exacerbation of Symptoms

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of the drug SM-13496 compared to a placebo and to haloperidol in patients with schizophrenia.

Study identification

NCT ID
NCT00044044
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
356 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2002 (Type not available)
Primary completion
May 2003 (Actual)
Completion
May 2003 (Actual)
Last update posted
Apr 17, 2014

2002 – 2003

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Birmingham Alabama 35209 —
Institute for Psychopharmacology Research Cerritos California 90703 —
CNS Network Garden Grove California 92845 —
California Clinical Trials Medical Group Glendale California 91206 —
Optimum Health Services La Mesa California 91942 —
University of California, Irvine Orange California 92868 —
Affiliated Research Institute San Diego California 92108 —
Sharp Mesa Vista Hospital San Diego California 92123 —
California Neuropsychopharmacolgoy Clinical Research Insitute San Diego California 92126 —
Comprehensive Neuroscience. Inc. Washington D.C. District of Columbia 20016 —
Comprehensive Neuroscience. Inc. Melbourne Florida 32935 —
Segal Institute for Clinical Research North Miami Florida 33161 —
University of South Florida Tampa Florida 33613 —
Coordinated Research of Florida, Inc. Winter Park Florida 32789 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Carman Research Smyrna Georgia 30080 —
Hawaii Research Center Honolulu Hawaii 96826 —
Alexian Brothers Behavioral Health Hospital Hoffman Estates Illinois 60194 —
American Medical Research Oak Brook Illinois 60523 —
Centers for Behavioral Health, LLC Rockville Maryland 20850 —
Lake Mead Hospital North Las Vegas Nevada 89030 —
Comprehensive Clinical Research CNS, PC Clementon New Jersey 08021 —
ClinSearch, Inc. Kenilworth New Jersey 07033 —
Psychiatric Professional Services Inc Cincinnati Ohio 45267 —
Quantum Clinical Services Group Philadelphia Pennsylvania 19139 —
Albert Einstein Medical Center - Dept. of Psychiatry Philadelphia Pennsylvania 19141 —
Community Clinical Research Austin Texas 78756 —
FutureSearch Trials Austin Texas 78756 —
Claghorn Lesem Research Clinic, Inc. Bellaire Texas 77401 —
St. Paul Medical Center Dallas Texas 75235 —
University Hills Clinical Research Dallas Texas 75235 —
CNS, Inc. Falls Church Virginia 22041 —
Northwest Clinical Research Center Belleview Washington 98004 —
Medstream, Inc. Milwaukee Wisconsin 53210 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00044044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00044044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →